ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NVS Novartis AG

98.86
1.13 (1.16%)
08 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Novartis AG NYSE:NVS NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  1.13 1.16% 98.86 99.19 98.54 98.60 1,159,818 00:50:51

Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)

26/01/2021 1:59pm

Edgar (US Regulatory)


Novartis AG
PO Box
CH 4002 Basel
 
 
 
 
US Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
 
 
 
 
 
 
January 26, 2021
 
 
 
 
 
Re:    Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
 
 
 
Ladies and Gentlemen:
 
 
 
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Novartis AG has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on January 26, 2021.
 
 
 
Respectfully submitted,
 
Novartis AG
 
 
 
 
 
/s/ SHANNON THYME KLINGER /s/ HARRY KIRSCH
Shannon Thyme Klinger Harry Kirsch
Chief Legal Officer Chief Financial Officer
of Novartis of Novartis

1 Year Novartis Chart

1 Year Novartis Chart

1 Month Novartis Chart

1 Month Novartis Chart

Your Recent History

Delayed Upgrade Clock